|Videos|April 19, 2023
Interview with LGM Pharma’s CEO, Prasad Raje
Author(s)LGM Pharma
Key Learning Objectives:
- LGM Pharma reports strong revenues in its first year of CDMO operations and continued growth in its API Sourcing business
- Offering API sourcing and CDMO services, plus Analytical Testing and new Drug Product R&D services, addresses the comprehensive needs of customers as LGM promotes its customer-centric strategies for growth.
- LGM Pharma elevated its API sourcing network with the 2020 acquisition of NexGen Pharma’s CDMO business – enabling the one company to provide comprehensive services.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Pharmaceutical Technology Is Now PharmTech: A Sharper Name for a Smarter Industry
2
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
3
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
4
GSK’s RSV Vaccine Approved in Europe
5